Molecular mechanisms for the regulation of aryl sulfotransferase IV expression during 2-acetylaminofluorene-induced hepatocarcinogenesis in rat
- 30 June 1994
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 92 (1-3) , 343-350
- https://doi.org/10.1016/0009-2797(94)90075-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hypomethylation of the rat aryl sulfotransferase IV gene and amplification of a DNA sequence during multistage 2-acetylaminofluorene hepatocarcinogenesisChemico-Biological Interactions, 1994
- Evidence of two separate mechanisms for the decrease in aryl sulfotransferase activity in rat liver during early stages of 2‐acetylaminofluorene–induced hepatocarcinogenesisMolecular Carcinogenesis, 1994
- Genomic structure of rat liver aryl sulfotransferase IV-encoding geneGene, 1993
- Reaction product inactivation of aryl sulfotransferase IV following electrophilic substitution by the sulfuric acid ester of N-hydroxy-2-acetylaminofluoreneCarcinogenesis: Integrative Cancer Research, 1992
- Sex-differentiated and growth-hormone-regulated mitoinhibition in rat liver during treatment with 2-acetylaminofluorene and partial hepatectomy in the resistant hepatocyte modelCarcinogenesis: Integrative Cancer Research, 1991
- Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by Nhydroxy-2-acetylaminofluoreneCarcinogenesis: Integrative Cancer Research, 1990
- Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluoreneCancer Letters, 1988
- Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activityCarcinogenesis: Integrative Cancer Research, 1987
- Rapid decrease in N-hydroxy-2-acetylaminofluorene sulfotransferase activity of liver cytosols from rats fed carcinogenBiochemical Pharmacology, 1983
- Enzyme-Catalyzed Reactions of the Carcinogen N -Hydroxy-2-fluorenylacetamide with Nucleic AcidScience, 1968